Two new reports from iData Research cover the US market for vascular access devices and the European markets for cardiac surgery and heart valve devices. The European interventional cardiology report covers markets for tissue heart ...
Tags: Medtech Markets, US market
Boston Scientific has reported the first two commercial implants of Lotus valve system in a German hospital. Dr Gerhard Schuler and Dr Axel Linke led the procedures at the Heart Center - University Hospital Leipzig, Germany. CE Mark ...
Tags: Boston Scientific, Lotus Valve
US-based Boston Scientific has obtained CE Mark approval for its Lotus valve system, a transcatheter aortic valve replacement (TAVR) device designed to treat patients with severe aortic stenosis who are at high risk with surgical valve ...
Tags: Lotus Valve System, Health, Medicine
Boston Scientific has completed enrolling first patient in REPRISE II clinical trial, designed to assess the safety and efficacy of the Lotus Valve system in minimizing aortic regurgitation (leaking). The Lotus Valve system, which the ...
Tags: Boston Scientific, first patient, REPRISE II clinical trial